Nih
Nih funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
RFA-OD-27-003: INCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)
This NIH NOFO funds high-risk, high-reward R21 projects focused on Down syndrome and co-occurring conditions through the INCLUDE Project in the 2026–2028 cycles.
RFA-OD-27-004: INCLUDE Project Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)
The NIH INCLUDE Project Transformative Research Awards program supports unusually innovative R01 applications focused on Down syndrome biology and co-occurring conditions with high-risk, high-reward approaches.
RFA-OD-27-005: INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)
A trans-NIH R61/R33 phased mechanism for developing and advancing translational clinical trials for co-occurring conditions in people with Down syndrome, with a maximum five-year project period and an upcoming 2026/2027 filing rhythm.
RFA-OD-27-008: Maximizing the Scientific Value of ECHO Data (NRSA F32 Postdoctoral Fellowship)
A National Institutes of Health Office of the Director fellowship call for postdoctoral researchers using Environmental Influences on Child Health Outcomes (ECHO) de-identified cohort data through the NICHD DASH repository, with applications due in December 2026 for FY 2027 start cycles.
RFA-RM-26-017: Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
NIH Common Fund R03 opportunity for U.S. teams to run one-year pilot projects using at least two Common Fund data sets and improve their utility through analysis, integration, and reusable tools.
Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed): 2027-FY Biomedical Instrumentation Seeding for US Institutions
NIH’s Seed Instrumentation Support (SIS) program supports one new shared biomedical instrument per eligible US institution to strengthen research capacity, with awards expected at up to $400,000 each and an estimated application due date of July 1, 2026.
Supplements, Facts First: A Digital Adventure for Every Age Challenge
NIH's ODS-led challenge runs in three phases and awards up to $869,000 in prizes to teams that redesign dietary supplement fact-sheet content into multi-modal digital experiences.
Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge 2026
The NIH TRDNT Challenge is a phased national prize competition for novel endogenous RNA-targeting technologies, with Phase I open through June 2026 and follow-on stages planned for 2026-2027.
The NIDDK Disorders of Gastrointestinal Interoception Consortium Clinical Centers (DGIC) (RFA-DK-27-117)
NIH has issued a forecasted RFA to fund up to six GI interoception clinical research centers plus a scientific data center to expand mechanisms-based work on gastrointestinal motility and interoceptive dysfunction beyond gastroparesis.